Filana Therapeutics Inc share price logo

Filana Therapeutics Inc Share Price

NASDAQ: FLNA

Small Cap

$1.99

+0.04

(+2.05%)

as on

Filana Therapeutics Inc Stock Performance

as on March 14, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.95
    $2.06
    downward going graph

    2.01%

    Downside

    3.52%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Filana Therapeutics Inc share price movements today

Previous Close
$1.95
Open
$2.00
Volume
678.3K
Day's Low - High
$1.95 - $2.06

Filana Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Filana Therapeutics Inc Stock Fundamentals & Key Indicators

Check Filana Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$955.0

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Filana Therapeutics Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Filana Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Filana Therapeutics Inc image
Filana Therapeutics Inc
NA$955.0NANA0.00%

Filana Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2007
Mar 2008
Jun 2008
Sep 2008
Total Revenue
-
-
-
-
Gross Profit
0
0
0
0
Operating Income
0
0
0
0
EBITDA
-
-
-
-
Interest Expense
0
0
0
0
Depreciation
-
-
-
-
Income Before Tax
0
-1
-1
0
Income Tax Expense
-
-
-
-
Net Income
0
-1
-1
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Filana Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2001
Dec 2002
Dec 2004
Dec 2005
Dec 2006
Dec 2007
Total Revenue
-
-
-
-
-
-
Gross Profit
0
-
0
0
0
0
Operating Income
-27
-4
-8
-1
-2
-3
EBITDA
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
Income Before Tax
-28
-4
-8
-1
-2
-3
Income Tax Expense
-
-
-
-
-
-
Net Income
-28
-4
-8
-1
-2
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Filana Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2003
Dec 2003
Mar 2004
Dec 2006
Sep 2007
Dec 2007
Mar 2008
Jun 2008
Sep 2008
Net Income
-
-
-
-
0
-
-1
-1
0
Operating Cash Flow
-
-
-
-
0
-
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
0
0
0
0
0
0
Change in Cash
-
-
-
-
0
-
0
0
0

Filana Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2001
Dec 2002
Dec 2003
Dec 2004
Dec 2005
Dec 2006
Dec 2007
Net Income
-28
-4
-
-8
-1
-2
-3
Operating Cash Flow
0
0
-
0
0
0
0
Investing Cash Flow
0
0
-
0
-
-
-
Financing Cash Flow
0
0
0
0
0
0
0
Change in Cash
0
0
-
0
0
0
0

Insights on Filana Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, FLNA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, FLNA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, FLNA stock has moved down by -92.4%

About Filana Therapeutics Inc

Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.
OrganisationFilana Therapeutics Inc
Headquarters999 Stinson Way, Suite 301 33411,West Palm Beach,USA
E-voting on sharesClick here to vote

FAQs

What is Filana Therapeutics Inc share price today?

Filana Therapeutics Inc share price today is $1.99 as on at the close of the market. Filana Therapeutics Inc share today touched a day high of $2.06 and a low of $1.95.

What is the 52 week high and 52 week low for Filana Therapeutics Inc share?

Filana Therapeutics Inc share touched a 52 week high of $ on and a 52 week low of $ on . Filana Therapeutics Inc stock price today i.e. is closed at $1.99,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Filana Therapeutics Inc's market capitalisation today?

Filana Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Filana Therapeutics Inc Stock (FLNA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Filana Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Filana Therapeutics Inc Shares that will get you 0.7538 shares as per Filana Therapeutics Inc share price of $1.99 per share as on March 14, 2026 at 1:29 am IST.

What is the minimum amount required to buy Filana Therapeutics Inc Stock (FLNA) from India?

Indian investors can start investing in Filana Therapeutics Inc (FLNA) shares with as little as ₹92.409 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹924.09 in Filana Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Filana Therapeutics Inc share’s latest price of $1.99 as on March 14, 2026 at 1:29 am IST, you will get 5.0251 shares of Filana Therapeutics Inc. Learn more about fractional shares .